Jundishapur Journal of Natural Pharmaceutical Products

Published by: Kowsar

Inhibition of Aldose Reductase and Red Blood Cell Sorbitol Accumulation by Extract of Capparis spinosa

Alireza Kheirollah 1 , Mohammad Aberumand 2 , * , Zahra Ramezani 3 and Fatemeh Amraee 2
Authors Information
1 Department of Biochemistry, Cellular and Molecular Research Center, Medical School, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
2 Department of Biochemistry, Medical School, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
3 Nanotechnology Research Center, Faculty of Pharmacy, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
Article information
  • Jundishapur Journal of Natural Pharmaceutical Products: November 01, 2015, 10 (4); e24331
  • Published Online: November 24, 2015
  • Article Type: Research Article
  • Received: October 4, 2014
  • Revised: January 24, 2015
  • Accepted: February 1, 2015
  • DOI: 10.17795/jjnpp-24331

To Cite: Kheirollah A, Aberumand M, Ramezani Z, Amraee F. Inhibition of Aldose Reductase and Red Blood Cell Sorbitol Accumulation by Extract of Capparis spinosa, Jundishapur J Nat Pharm Prod. 2015 ; 10(4):e24331. doi: 10.17795/jjnpp-24331.

Abstract
Copyright © 2015, School of Pharmacy, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care. 1998; 21(9): 1414-31[PubMed]
  • 2. Saraswat M, Muthenna P, Suryanarayana P, Petrash JM, Reddy GB. Dietary sources of aldose reductase inhibitors: prospects for alleviating diabetic complications. Asia Pac J Clin Nutr. 2008; 17(4): 558-65[PubMed]
  • 3. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature. 2001; 414(6865): 813-20[DOI][PubMed]
  • 4. Lorenzi M. The polyol pathway as a mechanism for diabetic retinopathy: attractive, elusive, and resilient. Exp Diabetes Res. 2007; 2007: 61038[DOI][PubMed]
  • 5. Tomlinson DR, Willars GB, Carrington AL. Aldose reductase inhibitors and diabetic complications. Pharmacol Therapeut. 1992; 54(2): 151-94[DOI]
  • 6. Bhatnagar A, Srivastava SK. Aldose reductase: congenial and injurious profiles of an enigmatic enzyme. Biochem Med Metab Biol. 1992; 48(2): 91-121[PubMed]
  • 7. Srivastava SK, Petrash JM, Sadana IJ, Ansari NH, Partridge CA. Susceptibility of aldehyde and aldose reductases of human tissues to aldose reductase inhibitors. Curr Eye Res. 1982; 2(6): 407-10[PubMed]
  • 8. Spite M, Baba SP, Ahmed Y, Barski OA, Nijhawan K, Petrash JM, et al. Substrate specificity and catalytic efficiency of aldo-keto reductases with phospholipid aldehydes. Biochem J. 2007; 405(1): 95-105[DOI][PubMed]
  • 9. Hyndman DJ, Flynn TG. Sequence and expression levels in human tissues of a new member of the aldo-keto reductase family. Biochim Biophys Acta. 1998; 1399(2-3): 198-202[PubMed]
  • 10. Lim SS, Jung SH, Ji J, Shin KH, Keum SR. Synthesis of flavonoids and their effects on aldose reductase and sorbitol accumulation in streptozotocin-induced diabetic rat tissues. J Pharm Pharmacol. 2001; 53(5): 653-68[PubMed]
  • 11. Sultan AO, Çelik TA. Genotoxic and Antimutagenic Effects of Capparis spinosaL. on theAllium cepaL. Root Tip Meristem Cells. Caryologia. 2009; 62(2): 114-23[DOI]
  • 12. Rahmani R, Mahmoodi M, Karimi M, Hoseini F, Heydari R, Salehi M. Effect of Hydroalcoholic Extract of Capparis Spinosa Fruit on Blood Sugar and Lipid Profile of Diabetic and normal Rats. Zahedan J Res Med Sci. 2013; 15(11): 34-8
  • 13. Eddouks M, Lemhadri A, Michel JB. Hypolipidemic activity of aqueous extract of Capparis spinosa L. in normal and diabetic rats. J Ethnopharmacol. 2005; 98(3): 345-50[DOI][PubMed]
  • 14. Eddouks M, Lemhadri A, Michel JB. Caraway and caper: potential anti-hyperglycaemic plants in diabetic rats. J Ethnopharmacol. 2004; 94(1): 143-8[DOI][PubMed]
  • 15. Brevard H, Brambilla M, Chaintreau A, Marion J-P, Diserens H. Occurrence of elemental sulphur in capers (Capparis spinosa L.) and first investigation of the flavour profile. Flavour Fragrance J. 1992; 7(6): 313-21[DOI]
  • 16. Sharaf M, el-Ansari MA, Saleh NA. Quercetin triglycoside from Capparis spinosa. Fitoterapia. 2000; 71(1): 46-9[PubMed]
  • 17. Sharaf M, El-Ansari MA, Saleh NAM. Flavonoids of four Cleome and three Capparis species. Biochem Systemat Ecol. 1997; 25(2): 161-6[DOI]
  • 18. Halder AB, Crabbe MJ. Bovine lens aldehyde reductase (aldose reductase). Purification, kinetics and mechanism. Biochem J. 1984; 219(1): 33-9[PubMed]
  • 19. Daly AK, Mantle TJ. Purification and characterization of the multiple forms of aldehyde reductase in ox kidney. Biochem J. 1982; 205(2): 373-80[PubMed]
  • 20. Aghel N, Rashidi I, Mombeini A. Hepatoprotective activity of Capparis spinosa root bark against CCl4 induced hepatic damage in mice. Iranian J Pharmaceut Res. 2010; 6(4): 285-90
  • 21. Hayman S, Kinoshita JH. Isolation and Properties of Lens Aldose Reductase. J Biol Chem. 1965; 240: 877-82[PubMed]
  • 22. Puppala M, Ponder J, Suryanarayana P, Reddy GB, Petrash JM, LaBarbera DV. The isolation and characterization of beta-glucogallin as a novel aldose reductase inhibitor from Emblica officinalis. PLoS One. 2012; 7(4)[DOI][PubMed]
  • 23. Reddy GB, Muthenna P, Akileshwari C, Saraswat M, Petrash JM. Inhibition of aldose reductase and sorbitol accumulation by dietary rutin. Current Science. 2011; 101(9): 1191-7
  • 24. Shinohara R, Ohta Y, Yamauchi M, Ishiguro I. Improved fluorometric enzymatic sorbitol assay in human blood. Clin Chim Acta. 1998; 273(2): 171-84[PubMed]
  • 25. Halder N, Joshi S, Gupta SK. Lens aldose reductase inhibiting potential of some indigenous plants. J Ethnopharmacol. 2003; 86(1): 113-6[PubMed]
  • 26. Mylari BL, Armento SJ, Beebe DA, Conn EL, Coutcher JB, Dina MS, et al. A novel series of non-carboxylic acid, non-hydantoin inhibitors of aldose reductase with potent oral activity in diabetic rat models: 6-(5-chloro-3-methylbenzofuran-2-sulfonyl)-2H-pyridazin-3-one and congeners. J Med Chem. 2005; 48(20): 6326-39[DOI][PubMed]
  • 27. A randomized trial of sorbinil, an aldose reductase inhibitor, in diabetic retinopathy. Sorbinil Retinopathy Trial Research Group. Arch Ophthalmol. 1990; 108(9): 1234-44[PubMed]
  • 28. Dagher Z, Park YS, Asnaghi V, Hoehn T, Gerhardinger C, Lorenzi M. Studies of rat and human retinas predict a role for the polyol pathway in human diabetic retinopathy. Diabetes. 2004; 53(9): 2404-11[PubMed]
  • 29. Terubayashi H, Sato S, Nishimura C, Kador PF, Kinoshita JH. Localization of aldose and aldehyde reductase in the kidney. Kidney Int. 1989; 36(5): 843-51[PubMed]
  • 30. Morrison AD, Clements Jr RS, Winegrad AI. Effects of elevated glucose concentrations on the metabolism of the aortic wall. J Clin Invest. 1972; 51(12): 3114-23[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments